Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign In
  • Home
  • World
    Sections
    • World Home
    • Middle East war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • Nato’s European members discuss 3% target for defence spending
    • James Dyson is right to fight for British strawberries
    • Demand for UK rented properties falls for first time since pandemic
    • Luxury real estate brokers charged with sex trafficking
    • ‘We need time’: Syrians in Europe resist calls to return home
  • UK
    Sections
    • UK Home
    • UK Economy
    • UK Politics
    • UK Companies
    • Personal Finance
    Most Read
    • Nato’s European members discuss 3% target for defence spending
    • James Dyson is right to fight for British strawberries
    • Demand for UK rented properties falls for first time since pandemic
    • Business leaders warn Reeves about the impact of her Budget tax rises
    • Can Farage turn Reform into a serious contender for government?
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Selfridges’ Thai co-owner says it overpaid for luxury store portfolio
    • James Dyson is right to fight for British strawberries
    • Murdoch family feud left hanging over media empire’s future
    • Demand for UK rented properties falls for first time since pandemic
    • Luxury real estate brokers charged with sex trafficking
  • Tech
    Sections
    • Tech Home
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
    Most Read
    • The AI agents are coming
    • Romania’s cancelled election is a lesson in social media manipulation
    • Meta donates $1mn to Trump’s inauguration fund
    • Google races to bring AI-powered ‘agents’ to consumers
    • Microsoft’s Suleyman hires ex-DeepMind staff for AI health unit
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Crypto
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
    Most Read
    • Dollar’s surge sparks biggest fall in emerging market currencies in 2 years
    • The astonishing success of Eurozone bailouts
    • New eras, same bubbles: the forgotten lessons of history
    • FCA looks to fill advice gap on pensions
    • UK fintech Stenn collapsed after Russia money laundering case drew scrutiny
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • James Dyson is right to fight for British strawberries
    • The western myth of the ‘guy we can do business with’
    • The AI agents are coming
    • Romania’s cancelled election is a lesson in social media manipulation
    • The astonishing success of Eurozone bailouts
  • Lex
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
    Most Read
    • Nasdaq’s board diversity rules struck down by US court
    • Why business should not ape football when it comes to pay
    • Winner Parmy Olson on AI: ‘It’s not uncontrollable’
    • Pay UK bosses like football stars, says Lord Spencer
    • Remote and offshore work could hurt audit quality, US regulator warns
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Mitch McConnell: ‘We’re in a very, very dangerous world right now’
    • Pat Boonnitipat expected to lose money on his debut film. It’s become an Asian cultural supernova
    • It’s party season — let the covert interiors appraisals begin
    • Murder at the Castle — Miss Merkel finds her freedom
    • Thought the petrol Jaguar was dead? Think again
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Lex
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Medical science

  • Thursday, 12 December, 2024
    The Big Read
    What other conditions could weight-loss drugs treat?

    Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’s

    A montage of the human organs overlaid with Novo Nordisk and Eli Lilly logos
  • Tuesday, 10 December, 2024
    Scientists find potential link between ultra-processed foods and cancer

    Fatty molecules also found in UPFs seen at high levels in colorectal tumours

    A University of South Florida researcher working in a lab
  • Friday, 29 November, 2024
    Undercover EconomistTim Harford
    Keep vaccines out of politics

    This is a time for treating people as individuals rather than as members of a tribe

  • Saturday, 23 November, 2024
    US politics & policy
    Covid lockdown sceptic is frontrunner to lead Trump health agency

    Jay Bhattacharya at the NIH would be the latest ally of Robert F Kennedy Jr to take a role overseeing US healthcare

    Jay Bhattacharya
  • Wednesday, 20 November, 2024
    Scientific research
    ‘Google Maps’ project for cells reveals their role in spread of disease

    Effort to understand cellular functions promises to unlock crucial information about personal health

    A multicoloured image of human lung tissue
  • Thursday, 14 November, 2024
    Diabetes
    Diabetics left without treatment as global rate of disease doubles

    Sharp rise in cases over 30 years compounded by millions of people lacking access to medication, Lancet study finds

    Someone using glucometer, checking blood sugar level
  • Wednesday, 13 November, 2024
    Genomics
    Gene screening can cut early disease deaths by 25%, study shows

    People prone to breast cancer and diabetes among beneficiaries of early testing

    A scan of radiotherapy treatment for breast cancer
  • Tuesday, 5 November, 2024
    Disease control and prevention
    UK health agencies join with Oxford Nanopore to speed up pathogen screening

    Initiative is part of growing international efforts to give early warning of pandemic threats

    A nurse takes a swab at a Covid-19 drive-through testing station for NHS staff in 2020
  • Monday, 4 November, 2024
    Moral Money
    The corporate researchers hoping to help fend off the next pandemic Premium content

    Abbott Laboratories’ ‘virus hunters’ are tracking disease risks exacerbated by climate change

    Hundreds of the black and white birds caught in action as they take off together towards the camera
  • Wednesday, 30 October, 2024
    Moral Money
    Genetic data debate pits nature conservation against tech innovation Premium content

    Also in today’s newsletter, can biodiversity credits avoid the blowback that’s hit the carbon credit market?

    People in front of a sign bearing the multicoloured COP16 logo
  • Thursday, 24 October, 2024
    FT Magazine
    Inside Israel’s fight to make fathers of its dead soldiers

    Since last October, the families of every fallen soldier have been offered postmortem sperm retrieval

    Frozen sperm straws stored in goblets within a liquid nitrogen tank
  • Tuesday, 22 October, 2024
    Stephen Bush
    The human race is suffering from success

    Treating today’s mental and physical conditions may be a challenge, but their prevalence is actually a good sign

    Ewan White illustration of a crowd of people under a spotlight
  • Monday, 21 October, 2024
    InterviewFT Collections
    AI Exchange

    In this monthly series, running alongside our existing Tech Exchange dialogues, FT journalists talk to the scientists, developers and business leaders exploring ever more applications for artificial intelligence, in every aspect of our lives

  • Thursday, 17 October, 2024
    Drugs research
    Weight-loss drugs show promise in tackling opioid and alcohol abuse

    Analysis points to potential of drugs such as Ozempic beyond tackling obesity and diabetes

    Ozempic injection pens are shown moving along a conveyor belt at the Novo Nordisk production facilities in Hillerod, Denmark. The pens are blue with visible labeling, and the setting appears to be part of a manufacturing process.
  • Friday, 11 October, 2024
    News in-depthArtificial intelligence
    The week that artificial intelligence swept the Nobel Prizes

    Awards for Sir Demis Hassabis, John Jumper and Geoffrey Hinton recognise how AI is changing our world

    A montage of from left, John Jumper, Sir Demis Hassabis, Geoffrey Hinton and John Hopfield with the Alphafold logo in the background
  • Wednesday, 9 October, 2024
    Anjana Ahuja
    Marburg outbreak in Rwanda shows some post-pandemic progress

    It is too early to know whether the prompt response to the virus is enough to turn the tide

    Andy Carter illustration of two scientists working on a vaccine as a virus looms large over them
  • Wednesday, 2 October, 2024
    Science
    Map of adult insect’s brain offers clues on neurological diseases

    International collaboration plotted 149 metres of biological wiring in fruit fly

    Caption: The fruit fly connectome contains a wide range of information, from cell types and synapses to neurotransmitters and network properties. Here, cells are color-coded by their defining chemical messenger. Blue: GABA; yellow: acetylcholine (ACH); pink: glutamate (GLUT).
  • Wednesday, 2 October, 2024
    Artificial intelligence
    DeepMind and BioNTech build AI lab assistants for scientific research

    Artificial intelligence used to help researchers plan experiments and better predict outcomes

    Montage of Google DeepMind and BioNTech logos with a finger on a smartphone in the foreground and semiconductor chip design in the background
  • Monday, 30 September, 2024
    Roche Holding AG
    Roche plans to launch drugs and slash development costs

    Swiss pharma group is a high spender on R&D but has had misses in Alzheimer’s and cancer

    A Roche Research laboratory
  • Friday, 27 September, 2024
    FT Magazine
    Inside the ‘killer cell’ factory

    The next stage in the war on cancer may be enlisting patients’ own blood cells to fight the disease

    Two men dressed in business suits standing side by side under a tree
  • Thursday, 26 September, 2024
    Anthony McDonnell
    Antimicrobial resistance is dangerous in more ways than one

    The reduced effectiveness of antibiotics risks severe disruption to the global economy

    Staff members work on the production line of penicillin antibiotics
  • Tuesday, 17 September, 2024
    Drugs research
    AstraZeneca and MSD hail progress in tackling hard-to-treat cancers

    Results offer hope of progress in combating bladder tumours and some forms of breast cancer

    Doctor examines mammogram of breast
  • Saturday, 14 September, 2024
    FT Magazine
    Storytelling with the pioneer of ‘narrative medicine’

    Rita Charon believes that letting patients tell their own stories is the best way to fix a broken system

    Rita Charon standing beside a wall filled with shelves of books and floor lamp
  • Thursday, 12 September, 2024
    Special ReportFT Health: Communicable Diseases
    Bird flu and mpox show little learnt from Covid about future pandemics

    More aggressive actions and better co-ordinated responses needed to contain viruses, say public health experts

    Several workers dressed in white protective coveralls are attending to rows of chickens inside a poultry farm
  • Thursday, 12 September, 2024
    Thomas Frieden
    We must strengthen public health surveillance to stop disease outbreaks

    Flying blind is dangerous. Technology can build on the basics of local and national data collection

    An individual wearing a white protective lab coat, gloves, and glasses is opening what seems to be a cryogenic tank
Previous page You are on page 1 Next page

Join us at an FT Live event

Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

FT Live
US Pharma and Biotech Summit
How the new market cycle will finance the next period of investing in innovation
Thursday, 15 May 2025New York, NY, USA
Explore all events

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareersSuppliers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsSubscription ManagerNews feedNewslettersCurrency Converter

Community & Events

FT Live EventsFT ForumsBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2024. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Edition:UK
International
Subscribe for full access

Top sections

  • Home
  • World
    • Middle East war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
  • UK
    • UK Economy
    • UK Politics
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
  • Markets
    • Alphaville
    • Markets Data
    • Crypto
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Lex
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Alphaville
  • FT Edit
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Schools
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • FT Digital Edition
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In